Market Herald logo


Be the first with the news that moves the market
  • CIMIC subsidiary UGL has finally settled a class action served by investors Clime Capital nearly two years ago
  • Clime Capital had alleged UGL kept the investor in the dark on continuing costs and working issues at INPEX’s WA offshore lithium project ‘Ichthys’
  • When UGL officially broke the news of issues at the project, Clime gunned for tens of millions of dollars – citing these losses from a UGL share pricing slump and being kept from the news beforehand
  • Details from today’s settlement have not been publicly revealed and are still pending on approval by the Federal Court of Australia

It’s been close to two years since CIMIC’s engineering subsidiary, UGL, was taken to court over a class action filed by investment group Clime Capital.

Then, Clime Capital alleged UGL had failed to inform the investors about additional costs and working problems during its contracted work for INPEX’s WA offshore lithium gas project – the Ichthys Plan during, 2014.

The class action was filed through the Victorian district registry of the Federal Court, signalling UGL had breached disclosure obligations and even engaged in deceptive conduct towards Clime Capital.

The management at Clime decided to officially take action when its joint venture partner, CH2M Hill, had informed its own US shareholders on details of the delays and cost overruns at the project.

Today, however, CIMIC released a statement to ASX shareholders revealing the class action had settled.

“CIMIC Group Limited’s subsidiary, UGL Pty Limited (UGL), has reached an in-principle settlement agreement about a class action brought by certain shareholders who acquired an interest in UGL between 16 April 2014 and 5 November 2014,” read the statement.

CIMIC management went further to detail the settlement will bear no impact on forecasted earnings or profits.

Clime Capital’s relationship with UGL originally began from a several-million share purchase. This purchase preceded UGL taking the US$170 million contract at Ichthys.

“Clime’s decision to pursue this case as representative reflects our anger at UGL’s conduct in relation to the Ichthys project,” Clime Chairman John Abernathy commented back in 2017 during initial statements.

The original class action proceedings detailed Clime gunning for tens of millions of dollars in losses cited as part of a stock slump during November 2014.

This 2014 share price deficit came about after UGL officially revealed problems with the Ichthys contract – Clime Capital alleging it was kept in the dark about.

During November of 2014, UGL’s shares fell 15 per cent for total losses of nearly $5.89 apiece.

No official spoken statements have been issued today by either party on the class action settlement. Details on the settlement are yet to be released as well.

Today, CIMIC Group’s shares are trading at a 0.46 premium for $33.11 apiece in a $10.68 billion market cap.

Clime Capital’s share pricing is currently frozen at 94 cents per share.

Settlement decisions announced today are still subject to approval by the Federal Court of Australia.

CIM by the numbers
More From The Market Herald

" ASIC sues ANZ (ASX:ANZ) for credit law breaches under home loan introduction program

Australia’s corporate watchdog is suing big-four bank ANZ (ANZ) for breaching the Credit Act through its “introducer” program that resulted in some $18.5...

" AMP (ASX:AMP) flags $325m impairment ahead of demerger

Wealth management giant AMP (AMP) has opened the trading day red after announcing another $325 million in impairment charges ahead of its AMP
EML Payments (ASX:EML) - Non Executive Chairman, Peter Martin

" EML Payments (ASX:EML) shares spike on Irish regulatory respite

The EML Payments (EML) share price has spiked today after the company announced some long-awaited good news for its embattled Irish subsidiary, PFS

" Viva Energy (ASX:VEA) announces 2030 net-zero emission goals

Viva Energy (VEA) has announced 2030 net-zero emission goals for scopes one and two with a 10 per cent reduction for scope three.